A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
about
Pharmaceutical policies: effects on rational drug usePharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesPharmaceutical policies: effects on rational drug useToward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public goodInterventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?A new measure of medication affordabilityPrescription to over-the-counter deregulation in Canada: are we ready for it, or do we need to be?Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionImpact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.Public financing of pain management: leaky umbrellas and ragged safety nets.Utilization effects of prescription drug benefits in an aging populationQuantifying components of drug expenditure inflation: the British Columbia seniors' drug benefit planChanging prescribing patterns and increasing prescription expenditures in Medicaid.From physician to consumer: the effectiveness of strategies to manage health care utilization.Pharmacy utilization and the Medicare Modernization Act.Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid populationWhat impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.Income-Based Drug Coverage in British Columbia: Lessons for BC and the Rest of Canada.The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefitsPathways to the use of health services research in policy.Drug pricing and reimbursement decision making systems in Mongolia.Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease.Pharmacists as agents of change for rational drug therapy.Copayments for prescription medicines on a public health insurance scheme in Ireland.Drug reimbursement: indicators of inappropriate resource allocation.Evaluating reference-based pricing: initial findings and prospects.Governance structure reform and antibiotics prescription in community health centres in Shenzhen, China.Evaluating the impact of educational interventions on use of antithrombotics in Australia.A decade of growth in public and private pharmaceutical expenditures: the case of Belgium 1990-1999.Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.Principles and uses of academic detailing to improve the management of psychiatric disorders.Revenue streams and clinical discretion.Impact of a Restriction in Reimbursement on Proton Pump Inhibitors in Patients with an Increased Risk of Gastric Complications.
P2860
Q24244044-26FBB6F4-34B0-408C-BC14-1199DA92232CQ24246148-5970A271-CFF8-4E33-8219-341C3AEFDDFCQ24248087-1FB797DA-04B1-4EF0-A865-AF2ED962CCA9Q28768386-3B938FA8-67CC-4074-9BA1-78BB50C2C534Q33327179-4915B158-F30B-4C49-BF2F-BABF67184367Q33726650-2F648D8D-B0CC-4556-BB68-9D864A7A181DQ33945830-4FB86668-3FD3-4240-8838-C964842C0B17Q33998895-F8F85812-05D7-4CC0-ACE5-5FC0C4B08B9EQ34001855-ED18218E-15F6-4713-AFC6-74207C607847Q34011243-C8AF2203-2038-4E30-80AD-BE975B60B6FEQ34020812-69184FC6-FEF0-4677-B25E-AA693794CD53Q34077793-B0C5A9EB-20D0-43C9-91C6-469C5B2930C2Q34321762-8C0D73E7-7CD6-440D-825F-AF9977034150Q34623355-0D2A4F1C-9FF7-4A60-8125-855E3B344376Q34628685-337C4912-B1B6-467C-90A8-1C46ED816AE3Q35037191-4E88BDD5-79C3-4160-BB09-71808AB04F41Q36078786-31AA264B-624C-4EE5-908C-EA5F3D40E114Q36332023-3ADB0876-9EA6-40D4-A055-0BF3E5A4D753Q36699426-0B729CA2-697F-468A-BD0E-9A3091092A1BQ36978715-DED7D17F-D6B1-45FF-B529-662A24C97324Q37196554-F7F367F7-EAE5-458F-B10A-D4DDEC752637Q37335676-CAAD7331-73DF-476E-8BD6-1F5D73BBDC93Q37668291-E0F9BDE3-F002-426F-B30A-5EF6DF2FB2B3Q39411894-83E1F1BD-4D1E-4840-B86E-8259F4EDA7F2Q40433597-C124AFF3-2AE8-42FC-86B9-D170A058931BQ41027687-BDF77F1D-1524-4887-B823-95E7F884ECEEQ41879412-FBA14163-C19D-49B6-A245-E9C2CB80D7CAQ43012674-C8C20A79-EF24-4AC9-A9DB-B4C2F8C2215BQ43644546-C4855239-23AF-4542-82A6-AAAC5643C962Q46837247-EC6FE23E-1421-4F2F-9542-42CAF3D4F975Q47236274-0B551F08-9CC0-4DE0-88FB-8A2ABF137846Q51762075-D42AEE0A-4B75-456E-90C8-534D6F7BD16DQ51993730-2BBC7D87-1C94-4C01-8EE0-C63BA6EEC495Q53581648-86F117F9-CFA4-465A-9A44-0F78796E4AA4Q55130738-F5215788-E2BC-4206-BFDA-ED996F797A50
P2860
A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
A critical analysis of studies ...... esearch in need of discipline.
@en
A critical analysis of studies ...... esearch in need of discipline.
@nl
type
label
A critical analysis of studies ...... esearch in need of discipline.
@en
A critical analysis of studies ...... esearch in need of discipline.
@nl
prefLabel
A critical analysis of studies ...... esearch in need of discipline.
@en
A critical analysis of studies ...... esearch in need of discipline.
@nl
P2093
P356
P1433
P1476
A critical analysis of studies ...... esearch in need of discipline.
@en
P2093
Fortess EE
Ross-Degnan D
Soumerai SB
P304
P356
10.2307/3350399
P407
P577
1993-01-01T00:00:00Z